Trials / Terminated
TerminatedNCT04068805
Developing Affective HeaLth to Improve Adherence to Health Behaviors in Diabetes (DAHLIA II)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Happify Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Participants will be randomly assigned to either a positive affect skills intervention or a psychoeducation control group and assessed with questionnaires before, during, and after the 8-week program, as well as at 3 months, 6 months, and 12 months after the end of the program.
Detailed description
Participants will be randomly assigned to either the Diabetes positive affect skills intervention or a psychoeducation control group. Both programs last 8 weeks and take place on a simplified research version of the Happify platform. Participants assigned to the diabetes positive affect program will have full access to Happify, with a track that focuses on building skills for greater happiness, reducing stress, and coping better with diabetes displayed as the feature track. Participants assigned to the psychoeducation (control) condition will be asked to complete a series of polls on various wellbeing topics, and then provided with some social comparison data about how their responses compared with the responses of other users, as well as information about why the well being topic is important. Participants will be asked to complete questionnaires before, during, and after the 8-week program as well as 3 months, 6 months and 12 months follow-up questionnaires after the program is complete, at which point study participation will end.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Happify | An online platform for conveying techniques from positive psychology, cognitive-behavioral therapy, and mindfulness-based stress reduction. |
Timeline
- Start date
- 2020-08-31
- Primary completion
- 2021-04-01
- Completion
- 2022-07-12
- First posted
- 2019-08-28
- Last updated
- 2022-07-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04068805. Inclusion in this directory is not an endorsement.